Endothelial dysfunction in patients with spontaneous venous thromboembolism

Haematologica

Volumn 92, Issue 6, 2007, Pages 812-818

  Migliacci, Rino ^a   Becattini, Cecilia ^a   Pesavento, Raffaele ^b   Davi, Giovanni ^c   Vedovati, Maria Cristina ^a   Guglielmini, Giuseppe ^a   Falcinelli, Emanuela ^a   Ciabattoni, Giovanni ^c   Valle, Fabio Dalla ^b   Prandoni, Paolo ^b   Agnelli, Giancarlo ^a   Gresele, Paolo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Atherosclerosis; Endothelium; Thrombosis

Indexed keywords

BIOLOGICAL MARKER; CD40 LIGAND; PADGEM PROTEIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ANAMNESIS; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW; BRACHIAL ARTERY; CASE CONTROL STUDY; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROL GROUP; CONTROLLED STUDY; DEMOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; HYPEREMIA; MALE; NON INVASIVE PROCEDURE; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; THROMBOCYTE ACTIVATION; VASODILATATION; VENOUS THROMBOEMBOLISM; BLOOD; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; THROMBOEMBOLISM; VASCULAR ENDOTHELIUM; VEIN THROMBOSIS;

ADULT; AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MIDDLE AGED; THROMBOEMBOLISM; VASODILATION; VENOUS THROMBOSIS;

EID: 34347225154     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.10872     Document Type: Article

References (44)

1. Wiloughby S, Loscalzo J. Vascular control of platelet function. In: Platelets in thrombotic and non thrombotic disease: Pathophysiology, Pharmacology and Therapeutics. Gresele P, Page CP, Fuster V and Vermylen J, eds. Cambridge University Press, Cambridge, 2002. p. 432-55.
2. Reichenbach G, Momi S, Gresele P. Nitric oxide and its antithrombotic action in the cardiovascular system. Curr Drug Targets Cardiovasc Haematol Disord 2005;5:65-74.
3. Goldhaber SZ, Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997;277:642-5.
4. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence. Arch Intern Med 2002;162:1182-9.
5. Rosendaal FR, Heimerhorst FM, Vandenbroucke JP. Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 2002;22:201-10.
6. Marcucci R, Liotta AA, Cellai AP, Rogolino A, Gori AM, Giusti B, et al. Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism. Am J Med 2003;115:601-5.
7. Cattaneo M. Hyperomocysteinemia: a risk factor for arterial and venous thrombotic disease. Int J Clin Lab Res 1997;27:139-44.
8. Fatini C, Gensini F, Sticchi E, Battaglini B, Prisco D, Fedi S, et al. ACE DD genotype: an independent predisposition factor to venous thromboembolism. Eur J Clin Invest 2003;33:642-7.
9. Ageno W, Prandoni P, Romualdi E, Ghirarduzzi A, Dentali F, Pesavento R, et al. The metabolic syndrome and the risk of venous thrombosis: a case-control study. J Thromb Haemost 2006;4:1914-8.
10. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, Lensing AW, et al. An association between atherosclerosis and venous thrombosis. N Engl J Med 2003;348:1435-41.
11. Becattini C, Agnelli G, Prandoni P, Silingardi M, Salvi R, Taliani MR, et al. A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J 2005;26:77-83.
12. Prandoni P, Ghirarduzzi A, Prins MH, Pengo V, Davidson BL, Sorensen H, et al. Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis. J Thromb Haemost 2006;4:1891-6.
13. Reich LM, Folsom AR, Key NS, Boland LL, Heckbert SR, Rosamond WD, et al. Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism. J Thromb Haemost 2006;4:1909-13.
14. van der Hagen PB, Folsom AR, Jenny NS, Heckbert SR, O'Meara ES, Reich LM, et al. Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study. J Thromb Haemost 2006;4:1903-8.
15. Agnelli G, Becattini C. Venous thromboembolism and atherosclerosis: common denominators or different diseases? J Thromb Haemost 2006;4:1886-90.
16. Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation 2005;111:363-8.
17. Migliacci R, Gresele P. Smoking and impaired endothelium-dependent dilatation. N Engl J Med 1996;334:1674.
18. Felmeden DC, Spencer CGC, Blann AD, Beevers DG, Lip GYH. Low-density Lipoprotein Subfractions and cardiovascular risk in hypertension, relationship to endothelial dysfunction and effects of teatment. Hypertension 2003;41:528-33.
19. Perticone F, Sciacqua A, Maio R, Perticone M, Maas R, Boger RH, et al. Asymmetric dimethylarginine, L-arginine, and endothelial dysfunction in essential hypertension. J Am Coll Cardiol 2005;46:518-23.
20. Rodriguez CJ, Miyake Y, Grahame-Clarke C, Di Tullio MR, Sciacca RR, Boden-Albala B, et al. Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitus. Am J Cardiol 2005;96:1273-7.
21. Migliacci R, Falcinelli F, Imperiali P, Floridi A, Nenci GG, Gresele P. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis. Ital Heart J 2004;5:371-7.
22. Anderson TJ, Uehata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 1995; 26:1235-41.
23. Deanfield J, Donald A, Ferri C, Giannattasio C, Halcox J, Halligan S, et al. Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: A statement by the Working Group on Endothelin and endothelial factors of the European Society of Hypertension. J Hypertens 2005; 23:7-17.
24. Agnelli G, Prandoni F, Santamaria MG. Bagatella P, Iorio A, Bazzan M, et al. Three months versus one year oral anticoagulant therapy for idiopathic deep venous thrombosis. N Engl J Med 2004;345:165-9.
25. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Internal brachial artery reactivity task force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the International brachial artery reactivity task force. J Am Coll Cardiol 2002;39:257-67.
26. Gresele P, Migliacci R, Procacci A, De Monte P, Bonizzoni E. Prevention by a nitric oxide donatine aspirin, but not by aspirin, of the acute endothelial dysfunction induced by exercise in patients with intermittent claudication. Thromb Haemost 2007;97:444-50.
27. Gresele P, Guglielmini G, De Angelis M, Ciferri S, Ciofetta M, Falcinelli E, et al. Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. J Am Coll Cardiol 2003; 41:1013-20.
28. Ahn ER, Lander G, Jy W, Bidot CJ, Jimenez JJ, Horstman LL, et al. Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk. Thromb Res 2004; 114:143-8.
29. Davi G, Gresele P, Violi F, Basili S, Catalano M, Giammarresi C, et al. Diabetes mellitus, hypercolesterolemia and hypertension, but not vascular disease per se, are associated with persistent platelet activation in vivo: evidence derived from the study of peripheral arterial disease. Circulation 1997; 96:69-75.
30. Benjamin EJ, Larson MG, Keyes MJ, Mitchell GF, Vasan RS, Keaney JF Jr, et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 2004; 109:613-9.
31. Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation 2003; 108:2093-8.
32. Gokce N, Keaney JF Jr, Hunter LM, Watkins MT, Nedeljkovic ZS, Menzoian JO, et al. Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol 2003; 41:1769-75.
33. Khare A, Shetty S, Ghosh K, Mohanty D, Chatterjee S. Evaluation of markers of endothelial damage in cases of young myocardial infarction. Atherosclerosis. 2005;180:375-80.
34. Blann AD. Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years. Thromb Haemost 2006;95:49-55.
35. Chirinos JA, Heresi GA, Velasquez H, Jy W, Jimenez JJ, Ahn E, et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J Am Coll Cardiol 2005;45:1467-71.
36. Gerdsen K, Weber M, Langer F, Eifrig B, Lindhoff-Last E. Platelet activation markers in patients with venous thromboembolism without predisposing factors. Pathophysiol Haemost Thromb 2005;34:1-5.
37. Brunner H, Cockcrofr JR, Deanfield J, Donald A, Ferrannini E, Halcox J, et al. Endothelial function and dysfunction. Part I: association with cardiovascular risk factors and diseases. A statement by Working Group on Endothelial Factors of the Europena Society of Hypertension. J Hypertens 2005;23:233-46.
38. Prandoni P. Risk factors of recurrent venous thromboembolism: the role of residual vein thrombosis. Pathophysiol Haemost Thromb 2003/2004; 33:351-3.
39. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001;104:2649-52.
40. Blackman DJ, Morris-Thurgood JA, Atherton JJ, Ellis GR, Anderson RA, Cockcroft JR, et al. Endothelium-derived nitric oxide contributes to the regulation of venous tone in humans. Circulation 2000;101:165-70.
41. Hand MF, Haynes WG, Webb DJ. Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction. Kidney Int 1998;53:1068-77.
42. Hong C, Zhu F, Du D, Pilgram TK, Sicard GA, Bae KT. Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism. Atherosclerosis 2005;183:169-74.
43. Ray JG, Mamdani M, Tsuyuki RT, Anderson DR, Yeo EL, Laupacis A. Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med 2001; 161:1405-10.
44. Steffen LM, Folson AR, Cushman M, Jacobs DR, Rosamond WD. Greater fish, fruit and vegetable intakes are related to lower incidence of venous thromboembolism. Circulation 2007; 115:188-95.